# Prolium Bioscience jobs and careers

> 0 open roles at Prolium Bioscience as of October 23, 2026. Source: https://www.thejobsmap.com/company/prolium-bioscience

Prolium Bioscience is a clinical stage company developing PRO-203, a potential best-in-class, bispecific CD20xCD3 antibody for severe autoimmune diseases, including systemic sclerosis (SSc) and systemic lupus erythematosus (SLE). Founded and backed by RTW Investments, Prolium has assembled a team with deep experience in the development of therapeutics in autoimmune disease.

## Key facts

| | |
|---|---|
| Open roles | 0 |
| Employees | 1 to 10 |
| Website | https://proliumbio.com |

## Leadership

- Scott Requadt, Chief Executive Officer

## Common questions

### Is Prolium Bioscience hiring right now?

Prolium Bioscience has no open roles listed as of October 23, 2026. Roles appear here as soon as they are posted on Prolium Bioscience's careers site.

### Who leads Prolium Bioscience?

Scott Requadt, Chief Executive Officer, is at the top of Prolium Bioscience's org chart.

### How do I apply for a job at Prolium Bioscience?

Pick a role on Prolium Bioscience's TheJobsMap page and select Apply. Every listing links to the original posting on Prolium Bioscience's own careers site, so you apply directly with the employer.